null

APC Anti-Mouse CD274/PD-L1 Antibody [10F.9G2] (AGEL1640)

SKU:
AGEL1640
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Applications:
FC
Reactivity:
Mouse
Host Species:
Rat
Isotype:
IgG2a,k
Clone:
10F.9G2
Conjugation:
APC
$179 - $407
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Mouse CD274/PD-L1 Antibody [10F.9G2]

The Mouse CD274 (PD-L1) Monoclonal Antibody (APC Conjugated) 10F.9G2 (AGEL1640) is a powerful tool for researchers studying immune checkpoint molecules in the context of cancer immunotherapy and immunology. This monoclonal antibody, specific to CD274 (also known as PD-L1), is conjugated to allophycocyanin (APC), enabling easy detection and analysis in flow cytometry and other applications.CD274, or Programmed Death-Ligand 1 (PD-L1), is a key immune checkpoint protein that plays a crucial role in regulating T-cell responses and immune tolerance. By binding to its receptor PD-1 on T cells, PD-L1 helps tumors evade immune detection and suppresses immune responses in the tumor microenvironment. Targeting the PD-1/PD-L1 pathway has revolutionized cancer treatment, leading to the development of immune checkpoint inhibitors that unleash the immune system to attack cancer cells.

This monoclonal antibody, clone 10F.9G2, specifically recognizes mouse CD274/PD-L1, making it an essential tool for studying the expression and function of PD-L1 in various experimental models. Its APC conjugation allows for precise and sensitive detection of PD-L1 expression on different cell types, facilitating detailed analysis of immune responses and tumor immunity.Research using this antibody can provide insights into the mechanisms of immune evasion by tumors, the role of PD-L1 in immune checkpoints, and the potential for immunotherapy targeting the PD-1/PD-L1 axis in cancer. By understanding the complex interactions involving PD-L1, researchers can advance the development of novel immunotherapies and personalized treatment strategies for cancer patients.